VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |